
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
Morabito, F., Gentile, M., Mazzone, C., Rossi, D., Di Raimondo, F., Bringhen, S., Ria, R., Offidani, M., Patriarca, F., Nozzoli, C., Petrucci, M. T., Benevolo, G., Vincelli, I., Guglielmelli, T., GrasVolume:
118
Journal:
Blood
DOI:
10.1182/blood-2011-05-353995
Date:
November, 2011
Fichier:
PDF, 256 KB
2011